China Pharma Holdings closes $5 million registered direct offering

The NYSE American-listed company sold 2.5 million common shares at $2.00 each and said net proceeds will support working capital and general corporate purposes.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.